FinTrust Capital Advisors’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-34
| Closed | -$1.14K | – | 1363 |
|
2024
Q1 | $1.14K | Hold |
34
| – | – | ﹤0.01% | 1130 |
|
2023
Q4 | $1.1K | Sell |
34
-54
| -61% | -$1.75K | ﹤0.01% | 1107 |
|
2023
Q3 | $2.88K | Sell |
88
-2,407
| -96% | -$78.9K | ﹤0.01% | 958 |
|
2023
Q2 | $137K | Hold |
2,495
| – | – | 0.03% | 308 |
|
2023
Q1 | $137K | Hold |
2,495
| – | – | 0.03% | 307 |
|
2022
Q4 | $137K | Sell |
2,495
-15,303
| -86% | -$843K | 0.03% | 306 |
|
2022
Q3 | $911K | Buy |
17,798
+34
| +0.2% | +$1.74K | 0.23% | 103 |
|
2022
Q2 | $906K | Sell |
17,764
-497
| -3% | -$25.3K | 0.23% | 106 |
|
2022
Q1 | $888K | Buy |
+18,261
| New | +$888K | 0.2% | 108 |
|